| 1. | Atectura Breezhaler | Inh Kaps 150mcg/80mcg | Blist 30 Stk | 32.28 | 51.50 | 01.02.2023 |  |  |  | Nein | 67597001 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 2. | Atectura Breezhaler | Inh Kaps 150mcg/80mcg | Blist 90 Stk | 96.74 | 121.65 | 01.02.2023 |  |  |  | Nein | 67597002 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 3. | Atectura Breezhaler | Inh Kaps 150mcg/160mcg | Blist 30 Stk | 32.28 | 51.50 | 01.02.2023 |  |  |  | Nein | 67597003 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 4. | Atectura Breezhaler | Inh Kaps 150mcg/160mcg | Blist 90 Stk | 96.74 | 121.65 | 01.02.2023 |  |  |  | Nein | 67597004 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 5. | Atectura Breezhaler | Inh Kaps 150mcg/320mcg | Blist 30 Stk | 32.28 | 51.50 | 01.02.2023 |  |  |  | Nein | 67597005 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 6. | Atectura Breezhaler | Inh Kaps 150mcg/320mcg | Blist 90 Stk | 96.74 | 121.65 | 01.02.2023 |  |  |  | Nein | 67597006 | Novartis Pharma Schweiz AG | Indacaterolum | 21106 | 01.01.2021 |  |  |  |  | 03.04.50. | R03AK14 | 
						| 7. | Cinqaero | Inf Konz 25 mg/2.5 ml | Durchstf 2.5 ml | 141.81 | 170.65 | 01.02.2024 |  |  | L | Nein | 66340002 | Teva Pharma AG | Reslizumabum | 20662 | 01.10.2018 |  |  |  |  | 03.04.50. | R03DX08 | 
						| 8. | Cinqaero | Inf Konz 100 mg/10 ml | Durchstf 10 ml | 567.21 | 633.30 | 01.02.2024 |  |  | L | Nein | 66340003 | Teva Pharma AG | Reslizumabum | 20662 | 01.06.2018 |  |  |  |  | 03.04.50. | R03DX08 | 
						| 9. | Daxas | Filmtabl 500 mcg | 30 Stk | 54.06 | 75.20 | 01.12.2022 |  |  |  | Nein | 60484001 | AstraZeneca AG | Roflumilastum | 19760 | 01.02.2012 |  |  |  |  | 03.04.50. | R03DX07 | 
						| 10. | Daxas | Filmtabl 500 mcg | 90 Stk | 137.85 | 166.35 | 01.12.2022 |  |  |  | Nein | 60484002 | AstraZeneca AG | Roflumilastum | 19760 | 01.11.2012 |  |  |  |  | 03.04.50. | R03DX07 |